Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-23-000108
Filing Date
2023-08-09
Accepted
2023-08-09 16:03:32
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20230630.htm   iXBRL 10-Q 914495
2 EX-31.1 exhibit31-1q22023.htm EX-31.1 9065
3 EX-31.2 exhibit31-2q22023.htm EX-31.2 9067
4 EX-32.1 exhibit32-1q22023.htm EX-32.1 3995
5 EX-32.2 exhibit32-2q22023.htm EX-32.2 3830
  Complete submission text file 0001125345-23-000108.txt   5200304

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20230630.xsd EX-101.SCH 43369
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20230630_cal.xml EX-101.CAL 46407
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20230630_def.xml EX-101.DEF 238355
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20230630_lab.xml EX-101.LAB 492170
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20230630_pre.xml EX-101.PRE 353128
55 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20230630_htm.xml XML 622316
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 231155022
SIC: 2834 Pharmaceutical Preparations